Hiromi Okushima

This inventor holds 10 USPTO granted patents. Top assignees: Mitsubishi Chemical Industries Limited, Mitsubishi Kasei Corporation. Active years: 1980-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiromi Okushima. Retrieved from https://idiyas.com/inventor/hiromi-okushima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 26(Granted Patents)

Company Filing History:

5 out of 614

Mitsubishi Chemical Industries Limited

patents

5 out of 499

Mitsubishi Kasei Corporation

patents

Years Active: 1980-1993

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5246958 - Antihypertensive thiocarbamoylascetonitrile compounds (1993-09-21),

2. 5202351 - 1-phenylalkyl-3-phenylurea derivative (1993-04-13),

3. 5126483 - 1-phenylalkyl-3-phenylurea derivatives (1992-06-30),

4. 5053409 - Aminobenzenesulfonic acid derivatives (1991-10-01),

5. 4971968 - Pyridazinone derivatives and salts thereof (1990-11-20),

6. 4822797 - Piperazinyl carbonyl phenyl pyridazinone derivatives useful as (1989-04-18),

7. 4661484 - Pyridazinone derivatives and salts thereof as cardiac stimulants (1987-04-28),

8. 4323500 - Method for preparing 7.alpha.-acylthio-4-en-3-oxosteroids (1982-04-06),

9. 4265816 - Process for preparing steroid-carboxylates (1981-05-05),

10. 4213902 - Process for producing steroidal 7.alpha.-acylthio-4-en-3-ones (1980-07-22),

Title: Hiromi Okushima: Innovator in Antihypertensive Compounds

Introduction

Hiromi Okushima is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive compounds. With a total of 10 patents to his name, Okushima's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, Okushima has developed antihypertensive thiocarbamoylascetonitrile compounds. These pharmaceutical compositions include thiocarbamoylacetonitrile, which has a specific chemical formula that allows for various substitutions. Another significant invention is a novel 1-phenylalkyl-3-phenylurea derivative, which is designed to reduce cholesterol in the blood by inhibiting ACAT. This derivative is useful for treating conditions such as hyperlipemia and atherosclerosis.

Career Highlights

Okushima has worked with prominent companies in the chemical and pharmaceutical industries, including Mitsubishi Chemical Industries Limited and Mitsubishi Kasei Corporation. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Some of his notable coworkers include Makio Kobayashi and Rikizo Furuya. Their collaboration has likely fostered an environment of innovation and creativity in their respective fields.

Conclusion

Hiromi Okushima's contributions to the field of antihypertensive compounds exemplify the importance of innovation in pharmaceuticals. His patents reflect a commitment to improving health outcomes through scientific advancement.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]